(Q40400198)

20 September 2017

title

Inhibition of hepatitis B virus gene expression and replication by helioxanthin and its derivative (English)

1 reference

20 September 2017

1 reference

Ying Li

1

1 reference

20 September 2017

Lei Fu

2

1 reference

20 September 2017

Hosup Yeo

3

1 reference

20 September 2017

Ju-Liang Zhu

4

1 reference

20 September 2017

Chen-Kung Chou

5

1 reference

20 September 2017

Yueh-Hsiung Kou

6

1 reference

20 September 2017

Sheau-Farn Yeh

7

1 reference

20 September 2017

Elizabeth Gullen

8

1 reference

20 September 2017

David Austin

9

1 reference

20 September 2017

Yung-Chi Cheng

10

1 reference

20 September 2017

publication date

1 January 2005

1 reference

Antiviral Chemistry & Chemotherapy

20 September 2017

published in

1 reference

20 September 2017

volume

16

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

193-201

1 reference

Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Hepatitis B virus. The major etiology of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Peptide aptamers targeting the hepatitis B virus core protein: a new class of molecules with antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Treatment of chronic hepatitis B: current challenges and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Perspectives for the treatment of hepatitis B virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Characterization of novel human hepatoma cell lines with stable hepatitis B virus secretion for evaluating new compounds against lamivudine- and penciclovir-resistant virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Sensitivity of L-(-)2,3-dideoxythiacytidine resistant hepatitis B virus to other antiviral nucleoside analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Nucleic acid-based immune system: the antiviral potential of mammalian RNA silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine (PMEA) on human and duck hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Hepatitis B virus: old, new and future approaches to antiviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Roles of the three major phosphorylation sites of hepatitis B virus core protein in viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Therapy of chronic hepatitis B: current challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Asian-Pacific consensus statement on the management of chronic hepatitis B: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Inhibition of hepatitis B virus in mice by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Characterization of nuclease-resistant ribozymes directed against hepatitis B virus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Genetic control by a metabolite binding mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Hepatitis B virus biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Inhibition of hepatitis B virus expression and replication by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Synthesis and antiviral activity of helioxanthin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

21 January 2018

The hepatitis B virus

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600305

10.1177/095632020501600305

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference